Position in HALO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$103,941,584
-$1,689,736 QoQ
Shares Held
1,608,256
+2.5% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JUPITER ASSET MANAGEMENT LTD holds $304,105,196 across 12 Biotechnology names. HALO ranks #1 (34.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
This page
|
1,608,256 | $103,941,584 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
711,457 | $48,471,564 | |
| 3 | INCY |
Incyte Corp
|
482,642 | $45,426,264 | |
| 4 | EXEL |
Exelixis, Inc.
|
967,409 | $41,492,171 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
|
1,781,063 | $22,833,227 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
803,419 | $11,906,668 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
491,093 | $10,931,730 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
274,419 | $6,794,614 |
All Filings in HALO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $103,941,584 | 1,608,256 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $105,631,320 | 1,569,559 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $58,714,757 | 800,583 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $34,885,235 | 670,612 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,845,317 | 60,262 | Shares | Defined | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||